Skip to content
Advances in AAV analytics

Advances in AAV analytics

Advancements in adeno-associated virus (AAV) analytical toolset for improving process and product quality

With the growing use and development of recombinant AAV (rAAV) vectors for gene therapies, there is a increasing need for accurate and robust analytical methods to validate the quantity and quality of the product. Here we report three approaches used to advance OXGENE’s analytical toolset for rAAV vectors: development of an automated, high-throughput method for titration by qPCR, use of Nanopore sequencing to assess sequence fidelity and identify residual DNA contaminants, and use of transmission electron microscopy (TEM) imaging to assess product quality.

Download the resource to read on...

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.


Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.